Introduction {#S0001}
============

*Blastocystis hominis* (*B. hominis*) is an obligate anaerobic protozoan found in the human large intestine and is the most common eukaryotic organism reported in human faecal samples \[[@CIT0001]\]. The parasite is a zoonotic organism, found in birds and swine, and can be transmitted easily to humans via the oral-faecal route. The prevalence of *B. hominis* varies in different countries from 1.5% to 50% \[[@CIT0002]\]. At first it was thought that the organism is a non-pathogenic yeast, but later *B. hominis* was classified as a protozoan of the stramenopiles line \[[@CIT0003]\]. The pathogenesity of *B. hominis* is still in debate because this parasite is very common in the healthy population without causing any symptoms \[[@CIT0004], [@CIT0005]\]. However, some studies suggest that it is a potentially pathogenic protozoa and it was reported that *B. hominis* causes various problems such as watery diarrhoea, abdominal pain, bloating, fever, nausea and gastrointestinal problems \[[@CIT0005], [@CIT0006]\]. In addition, it was reported that *B. hominis* may contribute in colitis, terminal ileitis and rectal bleeding \[[@CIT0007], [@CIT0008]\]. *Blastocystis hominis* contributed to anaemia in children aged 8--10 years old as per one study \[[@CIT0009]\].

Aim {#S0002}
===

The aim of the study was to compare haematological indices in cases with *blastocystis hominis* infection with healthy controls.

Material and methods {#S0003}
====================

From 2001 to 2012, 97,600 stool examinations were done in 4 university hospitals. Parasites were observed in 46200 specimens. Of these cases, subjects with complete laboratory investigation (complete blood count -- CBC, ferritin, total iron binding capacity -- TIBC, and serum) were included in this study as the case. Of these cases, 6851 cases had only *B. hominis* infection. This retrospective study was carried out on 10786 subjects who visited the hospital for routine checkup. In this study, subjects who attended for routine checkup were included. Of 8761 cases with *B. hominis* infection, 6851 cases with complete laboratory examination were included. In this case control study, 6851 cases with *B. hominis* infection and 3615 controls were included. Age, haemoglobin (Hb), serum iron, TIBC, white blood cell count (WBC), red cell distribution width (RDW), platelet (PLT), mean corpuscular volume (MCV), haematocrit (HCT) and erythrocyte sedimentation rate (ESR) were recorded for cases and controls.

Statistical analysis {#S20004}
--------------------

SPSS software version 13.0 (Chicago, IL, USA) was used for analysis. Independent sample *t*-test and χ^2^ tests were used for comparison. A value of *p* \< 0.05 was considered significant.

Results {#S0005}
=======

Demographic features are shown in [Table I](#T0001){ref-type="table"}. There were significant differences between the two groups regarding distribution of iron levels, with the exception of iron level range 120--140 µg/dl ([Table I](#T0001){ref-type="table"}). For iron level \< 80 µg/dl, the relative frequency was significantly higher in the case group. For iron level \> 120 µg/dl, the relative frequency was significantly higher in the control group (*p* \< 0.05).

###### 

Demographic features among cases and controls

  Parameter                           Cases (n = 6851)     Controls (n = 3615)   Value of p
  --------------------- ------------- -------------------- --------------------- ------------
  Gender                              M = 4134, F = 3037   M = 1459, F = 2156    
  Age range \[years\]   0--10         5741 (83.80)         2977 (82.4%)          0.069
  11--20                322 (4.70%)   265 (7.3%)           \< 0.001              
  21--30                292 (4.27%)   193 (5.3%)           0.015                 
  31--40                240 (3.50%)   75 (2.1%)            \< 0.001              
  41--50                125 (1.82%)   46 (1.3%)            0.040                 
  51--60                80 (1.17%)    34 (0.9%)            0.256                 
  61--70                35 (0.52%)    17 (0.5%)            0.977                 
  71--80                14 (0.2%)     8 (0.2%)             0.907                 
  81--90                2 (0.02%)     0 (0.0%)             NA                    

Frequency of TIBC = 300--350 µg/dl and 400--450 µg/dl was higher among the cases, and the frequency of TIBC = 350--400 µg/dl was significantly higher among the controls ([Table II](#T0002){ref-type="table"}). There was a significant difference between the two groups regarding platelet count, with the exception of PLT \< 150,000/µl and PLT \> 450,000/µl ([Table II](#T0002){ref-type="table"}). Subjects with an eosinophil count of 1% were significantly more frequently in the case group than in the control group. The reverse was true for subjects with an eosinophil count of 2%. There was no significant difference between the two groups in eosinophil count in other ranges ([Table II](#T0002){ref-type="table"}).

###### 

Comparison between the two groups regarding haematological indices

  Parameter                                               Case (n = 6851)    Control (n = 3615)   Value of p
  --------------------------------------- --------------- ------------------ -------------------- ------------
  ESR, mean ± SD                                          11.16 ±8.67        10.32 ±5.01          \< 0.01
  Occult blood                            Pos             34 (0.49%)         0                    \< 0.001
  Hb (NL = 11--18 g/dl)                   \< 10           12 (0.16%)         11 (0.3%)            0.120
  10                                      98 (1.43%)      70 (1.9%)          0.063                
  11                                      427 (6.23%)     325 (9.0%)         \< 0.001             
  12                                      1120 (16.35%)   830 (23.0%)        \< 0.001             
  13                                      1122 (16.37%)   585 (16.2%)        0.826                
  14                                      1143 (16.70%)   323 (8.9%)         \< 0.001             
  15                                      2671 (39.00%)   1411 (39.0%)       0.986                
  16                                      194 (2.83%)     48 (1.3%)          \< 0.001             
  17                                      45 (0.65%)      6 (0.2%)           0.001                
  18                                      15 (0.22%)      5 (0.1%)           0.215                
  19                                      4 (0.06%)       1 (0.0%)           0.353                
  Fe \[µg/dl\]                            20--40          19 (0.27%)         0 (0%)               0.002
  40--60                                  206 (3.00%)     8 (0.2%)           \< 0.001             
  60--80                                  5888 (85.94%)   2702 (74.7%)       \< 0.001             
  80--100                                 674 (9.83%)     761 (21.1%)        \< 0.001             
  100--120                                58 (0.84%)      136 (3.8%)         \< 0.001             
  120--140                                6 (0.08%)       8 (0.2%)           0.152                
  TIBC (NL = 240--450 µg/dl)              \< 240          11 (0.16%)         8 (0.2%)             0.697
  240--300                                693 (10.11%)    374 (10.3%)        0.778                
  300--350                                3031 (44.24%)   1492 (41.3%)       0.003                
  350--400                                2003 (29.23%)   1486 (41.1%)       \< 0.001             
  400--450                                1099 (16.04%)   250 (6.9%)         \< 0.001             
  \> 450                                  14 (0.21)       5 (0.1%)           0.271                
  PLT (NL = 150000--450000/ml)            \< 150000       134 (1.95%)        75 (2.1%)            0.611
  150000--200000                          468 (6.83%)     328 (9.1%)         \< 0.001             
  200000--250000                          751 (10.97%)    263 (7.3%)         \< 0.001             
  250000--300000                          4127 (60.23%)   2336 (64.6%)       \< 0.001             
  300000--350000                          905 (13.20%)    251 (6.9%)         \< 0.001             
  350000--400000                          199 (2.90%)     168 (4.6%)         \< 0.001             
  400000--450000                          151 (2.20%)     114 (3.2%)         \< 0.001             
  \> 450000                               118 (1.72%)     80 (2.2%)          0.079                
  Eosinophil (%)                          1               719 (10.49%)       440 (12.2%)          0.008
  2                                       5387 (78.63%)   2751 (76.1%)       0.003                
  3                                       316 (4.61%)     189 (5.2%)         181                  
  4                                       150 (2.19%)     94 (2.6%)          0.185                
  5                                       98 (1.43%)      58 (1.6%)          0.484                
  6                                       49 (0.71%)      20 (0.6%)          0.527                
  7                                       58 (0.84%)      35 (1.0%)          0.440                
  8                                       21 (0.30%)      6 (0.2%)           0.287                
  9                                       19 (0.27%)      10 (0.3%)          0.700                
  10                                      19 (0.27%)      6 (0.2%)           0.491                
  \> 10                                   15 (0.22%)      6 (0.2%)           0.788                
  WBC count (NL = 4000--11000 cells/ml)   2000--2999      58 (0.84%)         66 (1.82%)           \< 0.001
  3000--3999                              447 (6.52%)     238 (6.59%)        0.907                
  4000--4999                              878 (12.81%)    352 (9.73%)        \< 0.001             
  5000--5999                              1491 (21.76%)   823 (22.77%)       0.239                
  6000--6999                              1487 (21.70%)   806 (22.30%)       0.486                
  7000--7999                              903 (13.18%)    553 (15.30%)       0.002                
  8000--8999                              864 (12.61%)    516 (14.27%)       0.016                
  9000--9999                              550 (8.02%)     210 (5.80%)        \< 0.001             
  10000--10999                            96 (1.40%)      33 (0.92%)         0.031                
  11000--11999                            29 (0.42%)      5 (0.14%)          0.042                
  12000--12999                            27 (0.39%)      8 (0.23%)          0.140                
  13000--13999                            21 (0.30%)      5 (0.13%)          0.100                
  CRP                                                     Pos: 100 (1.46%)   18 (0.5%)            \< 0.001

Discussion {#S0006}
==========

Occult blood was more common in the group with *B. hominis* infection compared to the control group. This may be due to colitis from the *B. hominis* infection. Leder *et al*. studied over 2800 healthy people over 15 months \[[@CIT0010]\]. They did not find significant correlation between clinical symptoms and the presence of *B. hominis*. In the study by Zuckerman *et al*., colonsocopy did not show any significant abnormality \[[@CIT0011]\]. In the study by Wakid on 1238 workers in the western region of Saudi Arabia, no significant correlation was found between blastocystis infection and occult blood \[[@CIT0012]\]. Our samples were collected from hospitals. These differences may be due to selection bias.

In our study the frequency of iron level \< 80 was significantly higher in subjects with *B. hominis* infection. In the study by El Deeb *et al*. on pregnant woman with iron deficiency anaemia compared to those without iron deficiency, the frequency of *B. hominis* was significantly higher in the first group \[[@CIT0013]\]. In another study by Yavasoglu *et al*., the rate of *B. hominis* infection was significantly higher among cases with iron deficiency anaemia \[[@CIT0014]\]. In the study by Cheng *et al*. haemoglobin, neutrophil count and haematocrit were decreased in subjects with *B. hominis* infection \[[@CIT0015]\]. In the recent study by El Deeb and Khodeer, the frequency of parasites was significantly higher in cases with iron deficiency (anaemia) compared to non-anaemic patients \[[@CIT0016]\].

Although the exact mechanism of iron deficiency in subjects with *B. hominis* was not understood, some studies showed invasion of *B. hominis* in the gastrointestinal tract and subsequent blood loss \[[@CIT0008]\]. In the literature, *B. hominis* was reported as the possible cause of acute abdomen in children \[[@CIT0017]\]. There is evidence regarding the presence of inflammation when *B. hominis* is present \[[@CIT0018]\]. Yavasoglu *et al*. did not find evidence that supported the invasion of mucosa \[[@CIT0014]\].

Another mechanism that may lead to the development of anaemia in blastocystis is that infected subjects may return to the molecular structure of *B. hominis*. Stenzel *et al*. showed that in the endocytic pathway of *B. hominis* cationic ferritin is essential \[[@CIT0019]\].

Although there have been several published studies regarding *B. hominis* infection, there are few publications on its association with haematological indices.

Limitations -- the method of this study was retrospective, and this is the main limitation.

Conclusions {#S0007}
===========

*Blastocystis hominis* is a possible factor in haematological abnormalities. Another cohort study on a healthy population is recommended for determination of the cause and effect relationship.

This study was supported by financial support from Student Research Committee of Ahvaz Jundishapur University of Medical Sciences (NO: 91S.83).
